IV Bags Market Size
The IV Bags Market size is projected to expand from USD 2.78 billion in 2025 and it is projected to reach USD 5.74 billion by 2033, registering a CAGR of 9.49% between 2026 to 2033.
The IV bags are used to deliver different clinical nutritional fluids such as sodium chloride or other parenteral nutrition to the patient's body to treat a specific disease such as chronic diseases. The patient's IV fluids for specific purposes include medication administration, fluid, and electrolyte replacement and balance maintenance, blood or blood product delivery, and nutrient and nutritional supplement delivery.
As per DataM Intelligence, IV Bags Market study analysis offers an in-depth outlook on the market containing quantitative and qualitative data. It gives an outlook and forecast of the global market based on market segmentation. It also provides global IV Bags Market size, and growth, along with the latest trends, opportunities, and forecast till 2033 for the global market with esteem to major countries such as the United States, Canada, Brazil, Germany, Italy, Spain, United Kingdom, Russia, European countries, United Arab Emirates, Saudi Arabia, South Africa, Japan, China, India, South Korea, Australia, and rest of the countries over the globe.
IV Bags Market - Strategic Insights
| Metrics | Details |
| Market CAGR | 9.49% |
| Segments Covered | By Type, By Material, By Size, By Application, By End User and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
To Get a Free Sample Click here
Market Dynamics
The IV bags market growth is driven by the rise in prevalence of different diseases such as cancer, and neurological disorders rising adoption of IV therapy to take proper treatment of diseases, the increase in the geriatric population, and research and development activities.
The rising adoption of parenteral nutrition therapy is expected to drive the market growth
The rising prevalence of different diseases such as cancer and cardiovascular diseases is expected to boost the market over the forecast period. In this case, parenteral nutrition is needed in an emergency case. The rising incidence of diseases such as malignancy, ischemic gut malady, gastrointestinal disorders, Crohn’s disease, and diabetic intricacies is propelled interest in parenteral nutrition. Increasing demand for parenteral nutrition therapy drives the IV bags market worldwide.
The leaching chemical from IV Bags will hamper the growth of the market
However, PVC bags are not suitable for everyone’s formulations such as blood products. Mainly, Polyvinyl chloride (PVC) material is used for IV bags. PVC is not inherently flexible, plasticizers are added to achieve desirable properties. These plasticizers are not covalently bound to the PVC matrix and thus can easily leach into the surrounding solutions. The Leaching and extraction of di (2-ethylhexyl) phthalate (DEHP) from PVC bags have been reported often, with most DEHP found in bags utilized where blood is stored and delivered, or lipophilic drugs enteral and parenteral nutrition admixtures. This will hamper the market growth.
Segmentation Analysis
The multi-chamber IV bags segment is expected to grow at the fastest CAGR during the forecast period
The multi-chamber IV bag segment is expected to boost the market over the period of the forecast. Multi-chamber IV bags provide numerous benefits, including improved patient safety because they reduce handling and the risk of contamination. Patients can receive standard mixtures of fluids such as lipids, amino acids, or glucose.
The multi-chamber bag preparation has a variety of specifications and has the characteristics of ready-to-use, strict quality standards, reasonable prescription, and other characteristics, which can decrease configuration and prescription errors, lower bloodstream infections, and meet the clinical nutritional needs of the patients. The key players offer the only multi-chamber IV bag product portfolio in the market. For instance, B. Braun offers multi-chamber IV bags such as 3-chamber IV bags for emulsion infusion for nutrition purposes and also offers dual chamber IV bags for the purpose of separate filling and storage of lipid emulsion until the mixing of the full solution just before administration to the patient. These bags are available in different sizes such as 50 ml, 100 ml, 500 ml, 1000 ml, and others.
Geographical Analysis
North America region holds the largest market share of the global IV bags market
North America dominates the market for IV bags and is expected to show a similar trend over the forecast period. It is estimated to hold a significant market size over the forecast period (2026-2033) owing to a rising elderly population with diseases such as cancer and respiratory diseases, an advanced healthcare system, and the presence of market players. Patients who are undergoing an operative process receive IVs that provide essential fluids like saline. To store these fluids requires IV bags.
The larger patient pool means more demand for IV bags in the region. In addition, the presence of competitors, acquisitions, and new product launches boosts the market growth in the North American region. It will address the shortage of IV fluids and is expected to manufacture 0.9% sodium chloride for injection.
Competitive Landscape
The IV bags market is a moderately competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market are Baxter, B. Braun Melsungen AG, Pfizer, Inc., Fresenius Kabi AG, JW Life Science, RENOLIT, PolyCine GmbH, Sealed Air, ANGIPLAST PVT. LTD, Shanghai Solve Care Co Ltd., Kraton Corporation, and Jiangxi Sanxin Medtec Co., Ltd. among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the IV bags market globally.
Baxter Healthcare
Overview:
Baxter Healthcare is an American multinational healthcare company founded in 1940, headquartered in United States. It is provides the wide range of parenteral nutrition portfolio including vitamins and lipids, premix IV solutions, and pharmacy workflow management, labeling and compounding technology.
Recent Development-
- March 2026: Fresenius Kabi launched new eco-friendly IV bags in Europe, utilizing PVC-free and DEHP-free materials to comply with evolving environmental and patient safety regulations.
- February 2026: Baxter International expanded its U.S. IV solutions manufacturing capacity by upgrading sterile fluid production lines, focusing on higher output of premixed IV bags to address rising hospital demand and drug shortage resilience.
- January 2026: ICU Medical introduced enhanced IV bag systems with integrated closed-system transfer technology, improving medication safety and reducing contamination risks in hospital settings.
- December 2025: B. Braun Melsungen AG expanded its IV fluid production facility in Southeast Asia, aiming to strengthen regional supply chains and meet increasing demand from emerging healthcare markets.
The global IV bags market report would provide access to approximately 80+ market data tables, 70+ figures, and in the range of 250+ (approximate) pages.
